Aurinia Pharmaceuticals Inc (AUPH) Event Aug. 04, 2022, 00:00 UTC 30 1 comments (28% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports 33% Loss Increase for 2022-06-30 Comment Full text
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event Aug. 04, 2022, 00:00 UTC 35 1 comments (61% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Reports Net Loss for 2022-06-30 Comment Full text
Pacific Biosciences of California Inc (PACB) Event Aug. 03, 2022, 20:44 UTC 19 1 comments (10% Negative) Pacific Biosciences of California, Inc. (PACB) Reports Q3 2022 Financial Results Comment Full text
Poseida Therapeutics (PSTX) Event Aug. 03, 2022, 20:29 UTC 19 1 comments (10% Negative) Poseida Therapeutics, Inc. (PSTX) Announces Clinical Trial Timeline Adjustment Comment Full text
Xencor Inc (XNCR) Event Aug. 03, 2022, 20:12 UTC 18 1 comments (30% Negative) XENCOR, INC. (XNCR) Reports Q3 2022 Financial Results Comment Full text
Vanda Pharmaceuticals Inc (VNDA) Event Aug. 03, 2022, 20:12 UTC 19 1 comments (19% Negative) VANDA PHARMACEUTICALS INC. (VNDA) Reports Q3 2022 Financial Results Comment Full text
Jazz Pharmaceuticals plc (JAZZ) Event Aug. 03, 2022, 20:07 UTC 17 1 comments (10% Negative) Jazz Pharmaceuticals plc (JAZZ) Reports Q3 2022 Financial Results Comment Full text
Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX) Event Aug. 03, 2022, 20:04 UTC 18 1 comments (30% Negative) MIRATI THERAPEUTICS, INC. (MRTX) Reports Q3 2022 Financial Results Comment Full text
Fate Therapeutics Inc (FATE) Event Aug. 03, 2022, 20:03 UTC 18 1 comments (10% Negative) FATE THERAPEUTICS, INC. (FATE) Reports Q3 2022 Financial Results Comment Full text
Personalis Inc (PSNL) Event Aug. 03, 2022, 20:01 UTC 18 1 comments (30% Negative) Personalis, Inc. (PSNL) Reports Q3 2022 Financial Results Comment Full text